SATB2 and colorectal carcinoma: Nuclear SATB2 immunostaining was observed in epithelial cells in 98/104 (94.2%) of non-involved colorectal tissues, while in cancer cells, SATB2-Ir was detected in 84/104 (80.8%) CRC cases.